EUVIMEDEUVIMED entdecken
Open Access

Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis

Ethan G Muhonen iD, Tyler M Yasaka, Brandon M Lehrich, Khodayar Goshtasbi, Peter Papagiannopoulos, Bobby A Tajudeen, Maie A St John, Jeremy P Harris, Frank P K Hsu, Edward C Kuan

Journal of Neurological Surgery Part B: Skull Base · 01.02.2023 · 84 (01) · 060-068

DOI: 10.1055/a-1733-9475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2023. Verfasst von Ethan G Muhonen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Orange, California, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Skull base chordomas are locally aggressive malignant tumors derived from the notochord remnant. There are limited large-scale studies examining the role and extent of surgery and radiation therapy.

Design

Analysis of the National Cancer Database (NCDB) was performed to evaluate the survival outcomes of various treatments, and to assess for predictors of overall survival (OS).

Participants

This is a retrospective, population-based cohort study of patients diagnosed with a clival/skull base chordoma between 2004 and 2015 in the NCDB. Main Outcome Measures The primary outcome was overall survival (OS).

Results

In all, 468 cases were identified. Forty-nine percent of patients received surgery and 20.7% had positive margins. Mean age at diagnosis was 48.4 years in the surgical cohort, and 55% were males. Of the surgical cohort, 33.8% had negative margins, 20.7% had positive margins, and 45.5% had unknown margin status. Age ≥ 65 (hazard ratio [HR]: 3.07; 95% confidence interval [CI]: 1.63–5.76; p < 0.001), diagnosis between 2010 and 2015 (HR: 0.49; 95% CI: 0.26–0.90; p = 0.022), tumor size >5 cm (HR: 2.29; 95% CI: 1.26–4.15; p = 0.007), and government insurance (HR: 2.28; 95% CI: 1.24–4.2; p = 0.008) were independent predictors of OS. When comparing surgery with or without adjuvant radiation, no survival differences were found, regardless of margin status (p = 0.66).

Conclusion

Surgery remains the mainstay of therapy. Advanced age (>65 years), large tumor size, and government insurance were predictors of worse OS. Whereas negative margins and the use of adjuvant radiation did not appear to impact OS, these may very well reduce local recurrences. A multidisciplinary approach is critical in achieving optimal outcomes in this challenging disease.

Schlagwörter

Stichwörter der Autor:innen

clival chordomainsurance statusmarginsnational cancer databasenotochord tumorsradiationskull base chordomaskull base surgerysurgical outcomes

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Orange, California, United States.
  • Department of Otolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, United States.
  • Department of Head and Neck Surgery, University of California, Los Angeles, Los Angeles, California, United States.
  • Department of Radiation Oncology, University of California, Irvine, Orange, California, United States.
  • Department of Neurological Surgery, University of California, Irvine, Orange, California, United States.

ORCID-Profile: Ethan G Muhonen

Zitieren

APA

Muhonen, E. G., Yasaka, T. M., Lehrich, B. M., Goshtasbi, K., Papagiannopoulos, P., Tajudeen, B. A., St John, M. A., Harris, J. P., Hsu, F. P. K., & Kuan, E. C. (2023). Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis. Journal of Neurological Surgery Part B: Skull Base, 84(01), 060-068. https://doi.org/10.1055/a-1733-9475

Vancouver

Muhonen EG, Yasaka TM, Lehrich BM, Goshtasbi K, Papagiannopoulos P, Tajudeen BA, et al. Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis. Journal of Neurological Surgery Part B: Skull Base. 2023;84(01):060-068. doi:10.1055/a-1733-9475

BibTeX
@article{Muhonen2023,
  author = {Muhonen, Ethan G and Yasaka, Tyler M and Lehrich, Brandon M and Goshtasbi, Khodayar and Papagiannopoulos, Peter and Tajudeen, Bobby A and St John, Maie A and Harris, Jeremy P and Hsu, Frank P K and Kuan, Edward C},
  title = {Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2023},
  volume = {84},
  number = {01},
  pages = {060--068},
  doi = {10.1055/a-1733-9475}
}
Kostenlos starten →